UCLA Links Chlorpyrifos to 2.5-Fold Parkinson's Risk via Disrupted Neuronal Protein Clearance

The case-control analysis used California's pesticide application records linked to residential histories to quantify cumulative chlorpyrifos exposure. Participants with prolonged proximity showed the elevated odds ratio; the design controlled for age, sex, and smoking but remained observational. Parallel mouse work exposed animals to aerosolized chlorpyrifos for 11 weeks, reproducing motor deficits and confirming autophagy disruption inside neurons.

Prior pesticide-Parkinson's associations existed for paraquat and rotenone, yet this study isolates chlorpyrifos and supplies a mechanistic bridge: blocked protein clearance produces the Lewy-body-like aggregates seen in human disease. The 2001 residential ban and 2021 agricultural limits reduce new exposures, but legacy soil and groundwater residues continue to affect agricultural communities years later.

Original reporting omitted dose-response gradients and failed to note that similar protein-clearance defects appear in genetic Parkinson's models, suggesting convergent pathways that could be targeted therapeutically. A stronger design would incorporate prospective biomarker tracking in exposed cohorts to test whether early autophagy markers predict conversion.

Next steps include testing whether enhancing proteasomal or lysosomal function in exposed individuals slows progression, with any preventive trial requiring at least 5,000 participants followed for seven years to detect meaningful incidence reduction.